Inrebic Capsule
Product Images NDC 59572-720

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Inrebic (NDC 59572-720). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Celgene Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image 01

A bar chart comparing percentage changes in spleen volume at 24 weeks relative to baseline between placebo and Fedratinib 400 mg groups. The x-axis separates the two groups with sample sizes noted, and the y-axis shows percentage changes ranging roughly from -80% to +100%. Bars for the placebo group vary mostly above and below zero, while those for the Fedratinib group show predominantly negative percentage changes.*

FDA Label Image

Image 02

A bar graph showing the percentage change in MF-SAF total symptom score to end of cycle 6 relative to baseline for two groups: Placebo (N=49) and Fedratinib 400 mg (N=71). The graph displays individual variations with bars extending positively and negatively along the y-axis, indicating the range of symptom score changes for each group.*

FDA Label Image

Image 03

A bar chart comparing the proportions of patients experiencing 50% or greater reduction in various symptoms between Fedratinib 400 mg and placebo groups. Symptoms include abdominal discomfort, pain under left ribs, early satiety, night sweats, itching, and bone or muscle pain. Fedratinib shows higher reductions across all symptoms compared to placebo.*

FDA Label Image

Chemical Structure (Inrebic 01)

Chemical structure of Fedratinib Hydrochloride, showing the molecular arrangement including a sulfonyl group, nitrogen heterocycles, and piperazine ring with associated hydrochloride and water molecules.*

FDA Label Image

Principal Display Panel (100 mg Capsule Bottle Label)

Label for Inrebic (fedratinib) capsules, 100 mg strength, oral dosage form. The label shows the product name, strength, and quantity of 120 capsules. It includes manufacturer information for Celgene Corporation, storage instructions, and a barcode with NDC 59572-720-12.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.